UBS’s TIANYIN PHARMACEUTICAL TPI Stock Holding History

UBS’s Portfolio TPI Stock Details TPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4K	Buy	+5,690	New	+$3.6K	﹤0.01%	9713
2014 Q1	–	Sell	-3,088	Closed	-$2K	–	11197
2013 Q4	$2K	Sell	3,088 -6,678	-68%	-$6.13K	﹤0.01%	10115
2013 Q3	$7K	Buy	9,766 +6,701	+219%	+$4.42K	﹤0.01%	9188
2013 Q2	$2K	Buy	+3,065	New	+$1.8K	﹤0.01%	9909

Other funds holding TPI

PAM

Pope Asset Management Memphis, Tennessee $162M AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RIM

Regent Investment Management Louisville, Kentucky $373M AUM 10.22% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BWFA

Baltimore-Washington Financial Advisors Columbia, Maryland $2.32B AUM 16.8% 1-Year Est. Return

UBS's TPI Position: Q3 2014 in Review

UBS opened a new position in TIANYIN PHARMACEUTICAL (TPI) in Q3 2014: 5,690 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #9713 among its holdings. This is a return to the name: UBS previously reported a position in TPI as recently as Q4 2013.

UBS first reported a position in TPI in Q2 2013 and has held it in 4 quarters since. The position peaked at $7K in Q3 2013. 7 funds tracked by Wall St. Rank hold TPI as of Q3 2014.

UBS held 5,690 shares of TIANYIN PHARMACEUTICAL worth $4K as of Q3 2014.
TIANYIN PHARMACEUTICAL was a new UBS position in Q3 2014.
TIANYIN PHARMACEUTICAL made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9713 holding.
UBS first reported a position in TIANYIN PHARMACEUTICAL in Q2 2013 and has held it in 4 quarters since.
UBS's TIANYIN PHARMACEUTICAL position peaked at $7K in Q3 2013.
7 funds tracked by Wall St. Rank held TIANYIN PHARMACEUTICAL as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.